NetScientific identifies, develops and commercialises transformative biomedical and healthcare technologies originating from leading universities, teaching hospitals and research institutes, with a focus on the United Kingdom and United States.
Mondo Visione September 16, 2013 | London Stock Exchange Welcomes Netscientific, 20th Technology Admission Of 2013
Cabume September 16, 2013 | Healthcare investor raises £30m through London IPO
Global University Venturing September 10, 2013 | UK-based commercialisation company NetScientific aims for £30m ($47m) with impending IPO.
Daily Express September 9, 2013 | Medical specialist NetScientific looks to raise £30million.
City A.M. September 9, 2013 | Former GlaxoSmithKline boss to make return to public market.
Sunday Times September 8, 2013 | Former Glaxo boss back with healthcare investor.
Conference: BMES, Seattle, September 2013 | Biomedical Engineering Society (BMES) Annual Meeting: September 25-28, 2013 Seattle, Washington. Washington State Convention Center.
Keystoneedge August 22, 2013 | Philadelphia's QLIDA Diagnostics developing next-generation biomarker diagnostics. Every year, about 715,000 Americans experience a heart attack and early action is critical to saving lives, says the Centers for Disease Control and Prevention.
Lab on a Chip August 15, 2013 | Microfluidics: Size-Selective Collection of Circulating Tumor Cells using Vortex Technology. A blood-based, low cost alternative to radiation intensive CT and PET imaging is critically needed for cancer prognosis and management of its treatment.
Lab on a Chip Issue 6, 2013 | Microfluidics: Microfluidic sample preparation for diagnostic cytopathology. The cellular components of body fluids are routinely analyzed to identify disease and treatment approaches.
PLOS ONE Journal June, 2013 | Altered Functionality of Anti-Bacterial Antibodies in Patients with Chronic Hepatitis C Virus Infection. Using comparative glycoproteomics, we have previously identified a glycoprotein that is altered in both amount and glycosylation as a function of liver cirrhosis.
Process Engineering May 9, 2013 | Method simplifies fluid flow design.
RD Magazine May 8, 2013 | Bioengineers simplify fluid flows by removing complex math.
Scientific/Vortex Publication | Nature Communications May 7, 2013 | Engineering fluid flow using sequenced nicrostructures.
UCLA Newsroom May 7, 2013 | UCLA bioengineers simplify fluid flows by removing complex math.
San Francisco, CA April 15, 2013 – Chronic Liver Disease Patients to use WANDA Remote Monitoring System in new Clinical Research Study | UCLA’s Wireless Health Institute and UCSF’s School of Medicine have secured funding for the implementation of a Clinical Research Study to show how to prevent Hospitalizations in Chronic Liver Disease Patients using WANDA’s Evidence-based Wireless Monitoring Analytics System.
Antiviral Research Volume 98, Issue 1, April 2013 | Chronic hepatitis B: What should be the goal for new therapies Chronic hepatitis B can currently be medically managed with either pegylated interferon-alpha (pegIFN-α) or one of the five nucleos(t)ide analog Direct Acting Antivirals (DAAs) that inhibit the hepatitis B virus (HBV) DNA polymerase.
Small Volume 9 Issue 5 March 11, 2013 | Microfluidics: Three Dimensional, Sheathless, and High-Throughput Microparticle Inertial Focusing Through Geometry-Induced Secondary Flows.The process of single-stream microparticle inertial focusing in a single focal plane without sheath fluids and external forces, all in a high-throughput manner, is described on page 685 by D. Di Carlo and co-workers.
Franklin Technology Partners of Southeastern Pennsylvania February 5, 2013 | Ben Franklin Approves $1.4M for 9 Philly-area startups. Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved $1,430,000 in funding for nine early-stage companies, including six IT companies, two life sciences companies and one alternative energy company.
London September 28, 2012 – MOF Technologies Wins Prestigious Annual Prize | NetScientific portfolio company MOF Technologies was recognized as the spin-out company in Northern Ireland with the greatest commercial potential on Thursday evening, winning the 2012 25k Award.
London June 25, 2012 – WANDA Inc. CTO Addresses US Congress | Professor Majid Sarrafzadeh, of the UCLA Wireless Health Institute and Chief Technology Officer of NetScientific portfolio company WANDA Inc., today addressed the US Congress on the subject of “Saving the Healthcare System”.
London May 21, 2012 - NetScientific Scientist Receives Prestigious Award | The CTO of Vortex Diagnostics Inc, a NetScientific portfolio company has received the prestigious Faculty Early Career Development (CAREER) award from the National Science Foundation, for “High-throughput Single-cell Biophysics.”
MEDCITY News: May 2, 2012 | A NetScientific company is developing a mobile mobile cardiac biomarker testing device could detect heart attacks faster
London March 27, 2012 - Vortex Diagnostics Inc. CTO receives Young Investigator award from U.S. Naval Research | Professor Dino Di Carlo, CTO of NetScientific portfolio company Vortex Diagnostics Inc, has received a Young Investigator Program award from the U.S. Office of Naval Research.
London October 13, 2011 - NetScientific Bioengineer Awarded Packard Fellowship for Science and Engineering | The David and Lucile Packard Foundation has named Dino Di Carlo a 2011 recipient of a Packard Fellowship for Science and Engineering.
London July 12, 2011 - Advanced Biosensors Patent Granted | NetScientific is pleased to announce that portfolio company Advanced Biosensors Inc. which specialises in medical diagnostics, has been issued aU.S. Patent, Number 7,975,547, entitled “Method and Apparatus for Interfacial Sensing”.
London (July 5, 2011) - Vortex Diagnostics CTO Demonstrates Record-Breaking Breast Cancer Cell Detection | The CTO of Vortex Diagnostics Inc, a NetScientific portfolio company has demonstrated real-time identification of rare breast cancer cells in blood with a record low false-positive rate of one cell in a million.early detection of cancer and for monitoring the efficiency of drug and radiation therapy.
London June 20, 2011 | NetScientific announces today that it has appointed Professor Paul Freemont, a pioneer in the emerging field of synthetic biology, to its Scientific Advisory Board.
UCLA Health and Medicine Newsroom: January 10, 2011 | UCLA Wireless Health Institute (WHI)
New York October 7, 2010 | Advanced BioSensors, Inc., a subsidiary of NetScientific America, Inc., has received a further tranche of its $5 million Series A financing round.